[Update: acute hypercapnic respiratory failure].

Update: akute hyperkapnische respiratorische Insuffizienz.

Journal

Medizinische Klinik, Intensivmedizin und Notfallmedizin
ISSN: 2193-6226
Titre abrégé: Med Klin Intensivmed Notfmed
Pays: Germany
ID NLM: 101575086

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 29 03 2017
accepted: 04 06 2017
revised: 17 05 2017
pubmed: 15 7 2017
medline: 16 7 2019
entrez: 15 7 2017
Statut: ppublish

Résumé

Hypercapnic respiratory failure is a frequent problem in critical care and mainly affects patients with acute exacerbation of COPD (AECOPD) and acute respiratory distress syndrome (ARDS). In recent years, the usage of extracorporeal CO Summarizing the state of the art in the management of hypercapnic respiratory failure with special regard to the role of ECCO Review based on a selective literature search and the clinical and scientific experience of the authors. Noninvasive ventilation (NIV) is the therapy of choice in hypercapnic respiratory failure due to AECOPD, enabling stabilization in the majority of cases and generally improving prognosis. Patients in whom NIV fails have an increased mortality. In these patients, ECCO Optimized use of NIV and lung-protective ventilation remains standard of care in the management of hypercapnic respiratory failure. Currently, ECCO

Sections du résumé

BACKGROUND BACKGROUND
Hypercapnic respiratory failure is a frequent problem in critical care and mainly affects patients with acute exacerbation of COPD (AECOPD) and acute respiratory distress syndrome (ARDS). In recent years, the usage of extracorporeal CO
OBJECTIVE OBJECTIVE
Summarizing the state of the art in the management of hypercapnic respiratory failure with special regard to the role of ECCO
METHODS METHODS
Review based on a selective literature search and the clinical and scientific experience of the authors.
RESULTS RESULTS
Noninvasive ventilation (NIV) is the therapy of choice in hypercapnic respiratory failure due to AECOPD, enabling stabilization in the majority of cases and generally improving prognosis. Patients in whom NIV fails have an increased mortality. In these patients, ECCO
CONCLUSION CONCLUSIONS
Optimized use of NIV and lung-protective ventilation remains standard of care in the management of hypercapnic respiratory failure. Currently, ECCO

Identifiants

pubmed: 28707030
doi: 10.1007/s00063-017-0318-5
pii: 10.1007/s00063-017-0318-5
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

234-239

Références

N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
Intensive Care Med. 2004 Jul;30(7):1303-10
pubmed: 15197438
Eur Respir J. 2005 Feb;25(2):348-55
pubmed: 15684302
Crit Care Med. 2006 May;34(5):1372-7
pubmed: 16540950
Lancet. 2009 Sep 26;374(9695):1082-8
pubmed: 19682735
Lancet. 2009 Oct 17;374(9698):1351-63
pubmed: 19762075
Am J Respir Crit Care Med. 2012 Jan 15;185(2):152-9
pubmed: 22016446
Eur Respir J. 2012 Sep;40(3):783-5
pubmed: 22941546
ASAIO J. 2012 Nov-Dec;58(6):616-21
pubmed: 22990284
Respir Care. 2012 Oct;57(10):1619-25
pubmed: 23013899
Intensive Care Med. 2013 May;39(5):847-56
pubmed: 23306584
Ann Am Thorac Soc. 2013 Aug;10(4):307-14
pubmed: 23952848
Crit Care. 2014 Jun 17;18(3):R124
pubmed: 24942014
Intensive Care Med. 2014 Dec;40(12):1969-70
pubmed: 25266134
N Engl J Med. 2015 Feb 19;372(8):747-55
pubmed: 25693014
Crit Care Med. 2015 Jul;43(7):1386-94
pubmed: 25768682
Intensive Care Med. 2015 Oct;41(10):1752-62
pubmed: 26109400
Curr Opin Crit Care. 2016 Feb;22(1):45-52
pubmed: 26627537
Pneumologie. 2015 Dec;69(12):719-756
pubmed: 26649598
Crit Care. 2016 Feb 10;20:36
pubmed: 26861596
Med Klin Intensivmed Notfmed. 2016 Apr;111(3):196-201
pubmed: 26902369
Thorax. 2016 Apr;71 Suppl 2:ii1-35
pubmed: 26976648
Med Klin Intensivmed Notfmed. 2016 Apr;111(3):186-95
pubmed: 27084180
Crit Care. 2016 May 12;20(1):130
pubmed: 27170273
ASAIO J. 2016 Jul-Aug;62(4):458-62
pubmed: 27195746
Crit Care. 2016 Jun 30;20(1):150
pubmed: 27357690
Intensive Care Med. 2016 Sep;42(9):1437-44
pubmed: 27456703
Intensive Care Med. 2016 Nov;42(11):1832-1833
pubmed: 27586995
Dtsch Med Wochenschr. 2016 Sep;141(18):e166-72
pubmed: 27598922
Dtsch Med Wochenschr. 2016 Nov;141(24):1758-1762
pubmed: 27903026
ASAIO J. 2017 Sep/Oct;63(5):659-665
pubmed: 28114193
Pneumologie. 2017 Apr;71(4):215-220
pubmed: 28407675

Auteurs

F Seiler (F)

Klinik für Innere Medizin V - Pneumologie, Allergologie, Intensivmedizin, Universitätsklinikum des Saarlandes, Kirrberger Str. 100, 66421, Homburg/Saar, Deutschland. frederik.seiler@uks.eu.
ECLS Center Saar, 66421, Homburg, Deutschland. frederik.seiler@uks.eu.

F C Trudzinski (FC)

Klinik für Innere Medizin V - Pneumologie, Allergologie, Intensivmedizin, Universitätsklinikum des Saarlandes, Kirrberger Str. 100, 66421, Homburg/Saar, Deutschland.
ECLS Center Saar, 66421, Homburg, Deutschland.

M Kredel (M)

Universitätsklinikum Würzburg, Klinik und Poliklinik für Anästhesiologie, 97080, Würzburg, Deutschland.

C Lotz (C)

Universitätsklinikum Würzburg, Klinik und Poliklinik für Anästhesiologie, 97080, Würzburg, Deutschland.

P M Lepper (PM)

Klinik für Innere Medizin V - Pneumologie, Allergologie, Intensivmedizin, Universitätsklinikum des Saarlandes, Kirrberger Str. 100, 66421, Homburg/Saar, Deutschland.
ECLS Center Saar, 66421, Homburg, Deutschland.

R M Muellenbach (RM)

Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Klinikum Kassel GmbH, 34125, Kassel, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH